Drug Shortage Report for MAR-MONTELUKAST
| Report ID | 206808 |
| Drug Identification Number | 02399997 |
| Brand name | MAR-MONTELUKAST |
| Common or Proper name | Montelukast |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-10-01 |
| Actual start date | 2023-10-11 |
| Estimated end date | 2024-10-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-10-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-10-12 | English | Compare |
| v3 | 2023-10-11 | French | Compare |
| v2 | 2023-10-11 | English | Compare |
| v1 | 2023-10-11 | English | Compare |
Showing 1 to 4 of 4